Postmarketing Reporting of Adverse Drug Reactions to the FDA: An Overview of the 1985 FDA Guideline
- 1 April 1986
- journal article
- research article
- Published by Springer Nature in Drug Information Journal
- Vol. 20 (2) , 151-156
- https://doi.org/10.1177/009286158602000206
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: